Research / XYL / Fundamental state Inspectable configuration
State dimensions Filing 0001524472-25-000037 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
87.31% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.26% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.26% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
6.09% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
46.54% · OPTIONAL · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.77% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
13.26% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.52% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.56% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 49 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 8/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 98.07%
Current 87.31%
Delta -10.76% Capex Intensity Increased
Previous 3.43%
Current 4.26%
Delta 0.83% Cash Generation Increased
Previous 1.59%
Current 13.26%
Delta 11.66% Growth Increased
Previous 1.77%
Current 6.09%
Delta 4.32% Inventory Pressure Decreased
Previous 49.40%
Current 46.54%
Delta -2.85% Margin Increased
Previous 37.12%
Current 38.77%
Delta 1.65% Profitability Increased
Previous 11.16%
Current 13.26%
Delta 2.09% R And D Intensity Decreased
Previous 2.71%
Current 2.52%
Delta -0.19% Sbc Intensity Decreased
Previous 0.58%
Current 0.56%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.